

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 7.79682832 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 5.81501805 |
| 3 | intestinal absorption (GO:0050892) | 5.65490147 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.65070358 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.65070358 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.56536927 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.56536927 |
| 8 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.56393341 |
| 9 | intestinal cholesterol absorption (GO:0030299) | 5.03599800 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.86380130 |
| 11 | homocysteine metabolic process (GO:0050667) | 4.85953119 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 4.85120308 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.79268978 |
| 14 | drug catabolic process (GO:0042737) | 4.77459387 |
| 15 | bile acid and bile salt transport (GO:0015721) | 4.75645473 |
| 16 | glomerular filtration (GO:0003094) | 4.74730042 |
| 17 | flavonoid metabolic process (GO:0009812) | 4.67164958 |
| 18 | cysteine metabolic process (GO:0006534) | 4.63543559 |
| 19 | oligosaccharide biosynthetic process (GO:0009312) | 4.61047541 |
| 20 | digestion (GO:0007586) | 4.57121267 |
| 21 | angiotensin maturation (GO:0002003) | 4.54778753 |
| 22 | regulation of bile acid biosynthetic process (GO:0070857) | 4.54020642 |
| 23 | urea cycle (GO:0000050) | 4.53426754 |
| 24 | urea metabolic process (GO:0019627) | 4.53426754 |
| 25 | drug transmembrane transport (GO:0006855) | 4.50085106 |
| 26 | regulation of cellular extravasation (GO:0002691) | 4.37280369 |
| 27 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.33023898 |
| 28 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.30194001 |
| 29 | tryptophan catabolic process (GO:0006569) | 4.29799490 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 4.29799490 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 4.29799490 |
| 32 | renal filtration (GO:0097205) | 4.25805435 |
| 33 | ethanol metabolic process (GO:0006067) | 4.21868271 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.15658883 |
| 35 | sulfate transmembrane transport (GO:1902358) | 4.13934552 |
| 36 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.12787554 |
| 37 | regulation of cholesterol homeostasis (GO:2000188) | 4.12707339 |
| 38 | bile acid metabolic process (GO:0008206) | 4.12264061 |
| 39 | antibacterial humoral response (GO:0019731) | 4.11886434 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.09225354 |
| 41 | tryptophan metabolic process (GO:0006568) | 4.07554502 |
| 42 | cobalamin metabolic process (GO:0009235) | 4.07424891 |
| 43 | glyoxylate metabolic process (GO:0046487) | 4.05707991 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.04253121 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.04253121 |
| 46 | proline metabolic process (GO:0006560) | 4.04036340 |
| 47 | epithelial structure maintenance (GO:0010669) | 4.03998957 |
| 48 | cellular ketone body metabolic process (GO:0046950) | 4.03398909 |
| 49 | NADH metabolic process (GO:0006734) | 4.02561136 |
| 50 | positive regulation of pseudopodium assembly (GO:0031274) | 4.00229457 |
| 51 | cellular response to zinc ion (GO:0071294) | 3.98525704 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 3.98116307 |
| 53 | kynurenine metabolic process (GO:0070189) | 3.97220878 |
| 54 | exogenous drug catabolic process (GO:0042738) | 3.96648323 |
| 55 | alpha-linolenic acid metabolic process (GO:0036109) | 3.95232383 |
| 56 | antimicrobial humoral response (GO:0019730) | 3.94493149 |
| 57 | proline biosynthetic process (GO:0006561) | 3.93580152 |
| 58 | drug transport (GO:0015893) | 3.93258888 |
| 59 | primary alcohol catabolic process (GO:0034310) | 3.91665088 |
| 60 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.90554881 |
| 61 | cellular glucuronidation (GO:0052695) | 3.89985554 |
| 62 | regulation of autophagic vacuole assembly (GO:2000785) | 3.88088377 |
| 63 | high-density lipoprotein particle remodeling (GO:0034375) | 3.85924407 |
| 64 | negative regulation of sterol transport (GO:0032372) | 3.82093958 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.82093958 |
| 66 | transcytosis (GO:0045056) | 3.81849194 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.81522385 |
| 68 | protein-lipid complex remodeling (GO:0034368) | 3.80362636 |
| 69 | macromolecular complex remodeling (GO:0034367) | 3.80362636 |
| 70 | plasma lipoprotein particle remodeling (GO:0034369) | 3.80362636 |
| 71 | short-chain fatty acid metabolic process (GO:0046459) | 3.79817285 |
| 72 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.77676739 |
| 73 | bile acid biosynthetic process (GO:0006699) | 3.77154406 |
| 74 | lysine metabolic process (GO:0006553) | 3.76913570 |
| 75 | lysine catabolic process (GO:0006554) | 3.76913570 |
| 76 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.76090224 |
| 77 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.76090224 |
| 78 | endocrine process (GO:0050886) | 3.76090224 |
| 79 | desmosome organization (GO:0002934) | 3.74818232 |
| 80 | phospholipid efflux (GO:0033700) | 3.73566910 |
| 81 | regulation of cGMP biosynthetic process (GO:0030826) | 3.72511672 |
| 82 | aromatic amino acid family metabolic process (GO:0009072) | 3.66892488 |
| 83 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.66557942 |
| 84 | serine family amino acid catabolic process (GO:0009071) | 3.65533947 |
| 85 | uronic acid metabolic process (GO:0006063) | 3.61471743 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.61471743 |
| 87 | regulation of vacuole organization (GO:0044088) | 3.59079435 |
| 88 | lipoprotein metabolic process (GO:0042157) | 3.58324698 |
| 89 | glucocorticoid biosynthetic process (GO:0006704) | 3.56686453 |
| 90 | regulation of pseudopodium assembly (GO:0031272) | 3.56564971 |
| 91 | GDP-mannose metabolic process (GO:0019673) | 3.56262475 |
| 92 | drug metabolic process (GO:0017144) | 3.55996202 |
| 93 | intestinal epithelial cell development (GO:0060576) | 3.54548143 |
| 94 | amino-acid betaine metabolic process (GO:0006577) | 3.54287078 |
| 95 | renal system process involved in regulation of blood volume (GO:0001977) | 3.54184870 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.51578509 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.50338364 |
| 98 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.49239415 |
| 99 | positive regulation of glycolytic process (GO:0045821) | 3.47907461 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.47505865 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.47505865 |
| 102 | sterol homeostasis (GO:0055092) | 3.47457878 |
| 103 | reverse cholesterol transport (GO:0043691) | 3.47133708 |
| 104 | auditory receptor cell differentiation (GO:0042491) | 3.46864510 |
| 105 | regulation of respiratory burst (GO:0060263) | 3.45392191 |
| 106 | sulfation (GO:0051923) | 3.45190470 |
| 107 | ketone body metabolic process (GO:1902224) | 3.44889824 |
| 108 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.43600007 |
| 109 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.43600007 |
| 110 | ethanol oxidation (GO:0006069) | 3.43328966 |
| 111 | cellular response to cadmium ion (GO:0071276) | 3.42877434 |
| 112 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.41750854 |
| 113 | low-density lipoprotein particle remodeling (GO:0034374) | 3.40646548 |
| 114 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.39740691 |
| 115 | cellular modified amino acid catabolic process (GO:0042219) | 3.39159926 |
| 116 | cholesterol efflux (GO:0033344) | 3.38723032 |
| 117 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.37698856 |
| 118 | regulation of systemic arterial blood pressure (GO:0003073) | 3.36847997 |
| 119 | fatty acid beta-oxidation (GO:0006635) | 3.36768307 |
| 120 | urate metabolic process (GO:0046415) | 3.36043021 |
| 121 | regulation of vitamin metabolic process (GO:0030656) | 3.33681947 |
| 122 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.32716177 |
| 123 | complement activation, alternative pathway (GO:0006957) | 3.29652879 |
| 124 | glycolipid catabolic process (GO:0019377) | 3.28994652 |
| 125 | response to nitrosative stress (GO:0051409) | 3.28562304 |
| 126 | endocrine pancreas development (GO:0031018) | 3.26972434 |
| 127 | arginine metabolic process (GO:0006525) | 3.26748668 |
| 128 | alpha-amino acid catabolic process (GO:1901606) | 3.23846282 |
| 129 | fructose metabolic process (GO:0006000) | 3.23479766 |
| 130 | fatty acid oxidation (GO:0019395) | 3.22818855 |
| 131 | sulfate transport (GO:0008272) | 3.22574570 |
| 132 | polyketide metabolic process (GO:0030638) | 3.21432977 |
| 133 | doxorubicin metabolic process (GO:0044598) | 3.21432977 |
| 134 | daunorubicin metabolic process (GO:0044597) | 3.21432977 |
| 135 | glutamate metabolic process (GO:0006536) | 3.20771764 |
| 136 | phospholipid homeostasis (GO:0055091) | 3.20537261 |
| 137 | cellular amino acid catabolic process (GO:0009063) | 3.20428662 |
| 138 | glutathione derivative metabolic process (GO:1901685) | 3.20163653 |
| 139 | glutathione derivative biosynthetic process (GO:1901687) | 3.20163653 |
| 140 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.18213848 |
| 141 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.17225300 |
| 142 | protein carboxylation (GO:0018214) | 3.17225300 |
| 143 | digestive system process (GO:0022600) | 3.16745199 |
| 144 | protein-lipid complex assembly (GO:0065005) | 3.16503246 |
| 145 | complement activation, classical pathway (GO:0006958) | 3.16402172 |
| 146 | lipid oxidation (GO:0034440) | 3.15363852 |
| 147 | benzene-containing compound metabolic process (GO:0042537) | 3.14065885 |
| 148 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.11763656 |
| 149 | fatty acid catabolic process (GO:0009062) | 3.11695889 |
| 150 | eosinophil chemotaxis (GO:0048245) | 3.09289281 |
| 151 | O-glycan processing (GO:0016266) | 3.08504500 |
| 152 | diacylglycerol metabolic process (GO:0046339) | 3.07585252 |
| 153 | epoxygenase P450 pathway (GO:0019373) | 3.04069085 |
| 154 | regulation of cGMP metabolic process (GO:0030823) | 3.03426980 |
| 155 | fucosylation (GO:0036065) | 2.99988431 |
| 156 | adhesion of symbiont to host cell (GO:0044650) | 2.95605907 |
| 157 | virion attachment to host cell (GO:0019062) | 2.95605907 |
| 158 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.95384130 |
| 159 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.93956609 |
| 160 | cGMP-mediated signaling (GO:0019934) | 2.93265096 |
| 161 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.91725094 |
| 162 | peptide hormone processing (GO:0016486) | 2.91062588 |
| 163 | glutathione biosynthetic process (GO:0006750) | 2.89381050 |
| 164 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.83202310 |
| 165 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.81296941 |
| 166 | membrane lipid catabolic process (GO:0046466) | 2.79672274 |
| 167 | arginine catabolic process (GO:0006527) | 2.77327485 |
| 168 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.76935138 |
| 169 | bicarbonate transport (GO:0015701) | 2.76574523 |
| 170 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.76367443 |
| 171 | positive regulation of fatty acid oxidation (GO:0046321) | 2.76066458 |
| 172 | primary alcohol metabolic process (GO:0034308) | 2.75166277 |
| 173 | glycoside metabolic process (GO:0016137) | 2.74407956 |
| 174 | eosinophil migration (GO:0072677) | 2.73517943 |
| 175 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.70164611 |
| 176 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.69548130 |
| 177 | membrane repolarization during action potential (GO:0086011) | 2.68168365 |
| 178 | receptor recycling (GO:0001881) | 2.66903823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.73483309 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45403290 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.05598189 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.19105419 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.00373199 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.90117169 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.42116845 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.87634095 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.79173135 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.58100201 |
| 11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.49208921 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.48645586 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.16991306 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.02608842 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.70422756 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.67246288 |
| 17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.65899414 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.27672463 |
| 19 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.17221798 |
| 20 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.15953953 |
| 21 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.10521006 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.60966168 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.57856207 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57717929 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57693888 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55805944 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55798854 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52951520 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48829298 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44146322 |
| 31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.41324699 |
| 32 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.40434921 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39163612 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38600270 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36428528 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35479991 |
| 37 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26966406 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24650354 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23851447 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22943529 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16796550 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14884138 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14403108 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14384156 |
| 45 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12249187 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10456425 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08762862 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08259049 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07818183 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06793137 |
| 51 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05386196 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04933446 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03855442 |
| 54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03603637 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02983951 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02884063 |
| 57 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02440365 |
| 58 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.01979484 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99955669 |
| 60 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98941040 |
| 61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98930585 |
| 62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98722432 |
| 63 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97398881 |
| 64 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95917299 |
| 65 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94765233 |
| 66 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.93992837 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93353073 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92508548 |
| 69 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92484947 |
| 70 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92130027 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92026785 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90590137 |
| 73 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90460773 |
| 74 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.90378063 |
| 75 | SA1_27219007_Chip-Seq_Bcells_Human | 0.89591968 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88508460 |
| 77 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88248484 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87844420 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86854073 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86829387 |
| 81 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86232380 |
| 82 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85253624 |
| 83 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83943552 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83464675 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82792919 |
| 86 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.82610695 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81179225 |
| 88 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80937919 |
| 89 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79272244 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.78765908 |
| 91 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.77979066 |
| 92 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.77717291 |
| 93 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.77679658 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77234517 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76821167 |
| 96 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75574144 |
| 97 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75249774 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.74929509 |
| 99 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.72508019 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72201904 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72021025 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71853318 |
| 103 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.71522593 |
| 104 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.71363785 |
| 105 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.71245722 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71104866 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.70869306 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70658940 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69682088 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68919770 |
| 111 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.68825570 |
| 112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.68724299 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.67903290 |
| 114 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.67799364 |
| 115 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.67323791 |
| 116 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.66564471 |
| 117 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.66091688 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.64519296 |
| 119 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62847095 |
| 120 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.60865798 |
| 121 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.59787689 |
| 122 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.59557957 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.59526502 |
| 124 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.59319548 |
| 125 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.59144658 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.59098568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.13070693 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.67075996 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.22554597 |
| 4 | MP0005365_abnormal_bile_salt | 4.69115499 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.17243869 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.84287102 |
| 7 | MP0003252_abnormal_bile_duct | 3.56993545 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.98334580 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 2.73668282 |
| 10 | MP0009840_abnormal_foam_cell | 2.73555726 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.68472014 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.60718499 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.48345865 |
| 14 | MP0005083_abnormal_biliary_tract | 2.46365594 |
| 15 | MP0005332_abnormal_amino_acid | 2.37426491 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.26948311 |
| 17 | MP0003195_calcinosis | 2.21015726 |
| 18 | MP0000462_abnormal_digestive_system | 2.17167888 |
| 19 | MP0003868_abnormal_feces_composition | 2.08686851 |
| 20 | MP0004043_abnormal_pH_regulation | 2.05639363 |
| 21 | MP0008004_abnormal_stomach_pH | 2.04838651 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.98336080 |
| 23 | MP0001873_stomach_inflammation | 1.89380009 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.84790205 |
| 25 | MP0003866_abnormal_defecation | 1.83683899 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.76326230 |
| 27 | MP0004147_increased_porphyrin_level | 1.69717394 |
| 28 | MP0001663_abnormal_digestive_system | 1.66490048 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.62777606 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.61649143 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.60994811 |
| 32 | MP0005381_digestive/alimentary_phenotyp | 1.56846210 |
| 33 | MP0000609_abnormal_liver_physiology | 1.55973455 |
| 34 | MP0003879_abnormal_hair_cell | 1.50601091 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.50145909 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.45333114 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.43442486 |
| 38 | MP0001765_abnormal_ion_homeostasis | 1.42468062 |
| 39 | MP0009379_abnormal_foot_pigmentation | 1.41578141 |
| 40 | MP0000490_abnormal_crypts_of | 1.39521336 |
| 41 | MP0004858_abnormal_nervous_system | 1.35390630 |
| 42 | MP0001764_abnormal_homeostasis | 1.33760061 |
| 43 | MP0002009_preneoplasia | 1.28492388 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.28091577 |
| 45 | MP0001664_abnormal_digestion | 1.27499212 |
| 46 | MP0001756_abnormal_urination | 1.21297347 |
| 47 | MP0003045_fibrosis | 1.21162725 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.19569512 |
| 49 | MP0000477_abnormal_intestine_morphology | 1.19450113 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14315144 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.11354573 |
| 52 | MP0005451_abnormal_body_composition | 1.09976690 |
| 53 | MP0010678_abnormal_skin_adnexa | 1.02449667 |
| 54 | MP0002006_tumorigenesis | 1.01177567 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 1.01000595 |
| 56 | MP0000538_abnormal_urinary_bladder | 1.00979602 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.00342937 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 0.99894804 |
| 59 | MP0002136_abnormal_kidney_physiology | 0.97148010 |
| 60 | MP0000537_abnormal_urethra_morphology | 0.96937438 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 0.94281840 |
| 62 | MP0006082_CNS_inflammation | 0.91147035 |
| 63 | MP0003186_abnormal_redox_activity | 0.89740037 |
| 64 | MP0005409_darkened_coat_color | 0.86827021 |
| 65 | MP0002796_impaired_skin_barrier | 0.86723411 |
| 66 | MP0008872_abnormal_physiological_respon | 0.83974665 |
| 67 | MP0005408_hypopigmentation | 0.83911754 |
| 68 | MP0002098_abnormal_vibrissa_morphology | 0.83499585 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.82905275 |
| 70 | MP0002971_abnormal_brown_adipose | 0.82514331 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.82149996 |
| 72 | MP0000516_abnormal_urinary_system | 0.82056633 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 0.82056633 |
| 74 | MP0002254_reproductive_system_inflammat | 0.81685115 |
| 75 | MP0003172_abnormal_lysosome_physiology | 0.81388220 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 0.80198858 |
| 77 | MP0009697_abnormal_copulation | 0.80121013 |
| 78 | MP0005670_abnormal_white_adipose | 0.79706955 |
| 79 | MP0002822_catalepsy | 0.79473852 |
| 80 | MP0009764_decreased_sensitivity_to | 0.79167922 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 0.77867034 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.77372523 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.76120476 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.75759858 |
| 85 | MP0009785_altered_susceptibility_to | 0.74814770 |
| 86 | MP0005448_abnormal_energy_balance | 0.72678443 |
| 87 | MP0003283_abnormal_digestive_organ | 0.72245569 |
| 88 | MP0008469_abnormal_protein_level | 0.71224684 |
| 89 | MP0000598_abnormal_liver_morphology | 0.70768918 |
| 90 | MP0001944_abnormal_pancreas_morphology | 0.69624381 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.69170880 |
| 92 | MP0003787_abnormal_imprinting | 0.68984925 |
| 93 | MP0003075_altered_response_to | 0.67546747 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.67470715 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.66020082 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.65307219 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.64206346 |
| 98 | MP0001188_hyperpigmentation | 0.63222631 |
| 99 | MP0000566_synostosis | 0.62726723 |
| 100 | MP0003724_increased_susceptibility_to | 0.61072868 |
| 101 | MP0005310_abnormal_salivary_gland | 0.59875591 |
| 102 | MP0000470_abnormal_stomach_morphology | 0.59367389 |
| 103 | MP0005166_decreased_susceptibility_to | 0.59268647 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.59251603 |
| 105 | MP0005535_abnormal_body_temperature | 0.59207692 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.58133232 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.57774206 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.57559480 |
| 109 | MP0002638_abnormal_pupillary_reflex | 0.57098605 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.56771246 |
| 111 | MP0003953_abnormal_hormone_level | 0.56765480 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.56674156 |
| 113 | MP0009763_increased_sensitivity_to | 0.56607534 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.56196251 |
| 115 | MP0005025_abnormal_response_to | 0.56054868 |
| 116 | MP0002928_abnormal_bile_duct | 0.55947675 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.54628525 |
| 118 | MP0001485_abnormal_pinna_reflex | 0.53928352 |
| 119 | MP0006054_spinal_hemorrhage | 0.52455921 |
| 120 | MP0004947_skin_inflammation | 0.52369230 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.51609551 |
| 122 | MP0005376_homeostasis/metabolism_phenot | 0.50218566 |
| 123 | MP0002132_abnormal_respiratory_system | 0.49670497 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.49624454 |
| 125 | MP0003878_abnormal_ear_physiology | 0.47333722 |
| 126 | MP0005377_hearing/vestibular/ear_phenot | 0.47333722 |
| 127 | MP0002060_abnormal_skin_morphology | 0.46929377 |
| 128 | MP0009053_abnormal_anal_canal | 0.46897061 |
| 129 | MP0000613_abnormal_salivary_gland | 0.45579415 |
| 130 | MP0003718_maternal_effect | 0.44209034 |
| 131 | MP0005334_abnormal_fat_pad | 0.43971685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased circulating renin level (HP:0003351) | 5.73182173 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.15657301 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.04718830 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.74417338 |
| 5 | Ileus (HP:0002595) | 4.57100833 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56262710 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.54060570 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.19216678 |
| 9 | Xanthomatosis (HP:0000991) | 4.13633229 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 4.07105582 |
| 11 | Malnutrition (HP:0004395) | 3.84061059 |
| 12 | Hyperammonemia (HP:0001987) | 3.82319967 |
| 13 | Deep venous thrombosis (HP:0002625) | 3.81692027 |
| 14 | Ketoacidosis (HP:0001993) | 3.80355020 |
| 15 | Hyperactive renin-angiotensin system (HP:0000841) | 3.78634158 |
| 16 | Gout (HP:0001997) | 3.68064899 |
| 17 | Hyperglycinuria (HP:0003108) | 3.67590119 |
| 18 | Fat malabsorption (HP:0002630) | 3.62624416 |
| 19 | Ketosis (HP:0001946) | 3.62235345 |
| 20 | Glycosuria (HP:0003076) | 3.56292278 |
| 21 | Abnormality of urine glucose concentration (HP:0011016) | 3.56292278 |
| 22 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.41129782 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.39155534 |
| 24 | Hyperaldosteronism (HP:0000859) | 3.38421356 |
| 25 | Abnormality of purine metabolism (HP:0004352) | 3.36641293 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.35454251 |
| 27 | Ventricular fibrillation (HP:0001663) | 3.32786328 |
| 28 | Hyperglycemia (HP:0003074) | 3.30480613 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.25209447 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.25209447 |
| 31 | Symptomatic seizures (HP:0011145) | 3.24953643 |
| 32 | Late onset (HP:0003584) | 3.22742647 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.17716359 |
| 34 | Abnormality of chloride homeostasis (HP:0011422) | 3.15383958 |
| 35 | Hyperglycinemia (HP:0002154) | 3.08486484 |
| 36 | Alkalosis (HP:0001948) | 3.07950307 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.07463230 |
| 38 | Flat acetabular roof (HP:0003180) | 3.07070169 |
| 39 | Proximal tubulopathy (HP:0000114) | 3.05326414 |
| 40 | Hypokalemia (HP:0002900) | 3.02311619 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.02126950 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.02126950 |
| 43 | Hypoglycemic seizures (HP:0002173) | 3.00862893 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00622983 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.96690332 |
| 46 | Hypolipoproteinemia (HP:0010981) | 2.96388911 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95295010 |
| 48 | Abdominal distention (HP:0003270) | 2.93407667 |
| 49 | Metabolic alkalosis (HP:0200114) | 2.88536050 |
| 50 | Congenital sensorineural hearing impairment (HP:0008527) | 2.86650365 |
| 51 | Hyperphosphaturia (HP:0003109) | 2.85591195 |
| 52 | Abnormality of magnesium homeostasis (HP:0004921) | 2.84069756 |
| 53 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.82984567 |
| 54 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.82984567 |
| 55 | Lethargy (HP:0001254) | 2.74447773 |
| 56 | Metabolic acidosis (HP:0001942) | 2.72795384 |
| 57 | Epidermoid cyst (HP:0200040) | 2.71402828 |
| 58 | Hemorrhage of the eye (HP:0011885) | 2.70640120 |
| 59 | Chronic diarrhea (HP:0002028) | 2.69909339 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67126781 |
| 61 | Exocrine pancreatic insufficiency (HP:0001738) | 2.64442696 |
| 62 | Hyponatremia (HP:0002902) | 2.62307284 |
| 63 | Abnormality of potassium homeostasis (HP:0011042) | 2.61127415 |
| 64 | Increased purine levels (HP:0004368) | 2.61010289 |
| 65 | Hyperuricemia (HP:0002149) | 2.61010289 |
| 66 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.56996271 |
| 67 | Visceral angiomatosis (HP:0100761) | 2.56363021 |
| 68 | Hematochezia (HP:0002573) | 2.56345795 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.56300600 |
| 70 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.56154380 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.53145434 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.53145434 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.51666495 |
| 74 | Hypercholesterolemia (HP:0003124) | 2.51522006 |
| 75 | Large for gestational age (HP:0001520) | 2.49813985 |
| 76 | Retinal atrophy (HP:0001105) | 2.48924170 |
| 77 | Complement deficiency (HP:0004431) | 2.48517229 |
| 78 | Hyperlipoproteinemia (HP:0010980) | 2.45944525 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.45715749 |
| 80 | Hepatic necrosis (HP:0002605) | 2.44371444 |
| 81 | Hyperparathyroidism (HP:0000843) | 2.44178961 |
| 82 | Insulin resistance (HP:0000855) | 2.43559022 |
| 83 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42547774 |
| 84 | Increased muscle lipid content (HP:0009058) | 2.40748833 |
| 85 | Widely patent fontanelles and sutures (HP:0004492) | 2.40330956 |
| 86 | Abnormality of vitamin metabolism (HP:0100508) | 2.39803025 |
| 87 | Abnormality of renin-angiotensin system (HP:0000847) | 2.39584937 |
| 88 | Bone cyst (HP:0012062) | 2.38944661 |
| 89 | Abnormal urine phosphate concentration (HP:0012599) | 2.37272968 |
| 90 | Abnormality of the common coagulation pathway (HP:0010990) | 2.36334950 |
| 91 | Esophageal varix (HP:0002040) | 2.36289594 |
| 92 | Cerebral edema (HP:0002181) | 2.35159659 |
| 93 | Acanthocytosis (HP:0001927) | 2.34869637 |
| 94 | Vascular calcification (HP:0004934) | 2.32255730 |
| 95 | Abnormal hemoglobin (HP:0011902) | 2.30817038 |
| 96 | Vomiting (HP:0002013) | 2.28389829 |
| 97 | Syncope (HP:0001279) | 2.26885008 |
| 98 | Focal segmental glomerulosclerosis (HP:0000097) | 2.25099649 |
| 99 | Abnormality of methionine metabolism (HP:0010901) | 2.24401534 |
| 100 | Facial shape deformation (HP:0011334) | 2.22873670 |
| 101 | Potter facies (HP:0002009) | 2.22873670 |
| 102 | Hemangiomatosis (HP:0007461) | 2.20220723 |
| 103 | Hypomagnesemia (HP:0002917) | 2.20135284 |
| 104 | Pili torti (HP:0003777) | 2.19373776 |
| 105 | Steatorrhea (HP:0002570) | 2.18770800 |
| 106 | Acute encephalopathy (HP:0006846) | 2.18098645 |
| 107 | Growth hormone excess (HP:0000845) | 2.16721780 |
| 108 | Abnormality of vitamin B metabolism (HP:0004340) | 2.16223359 |
| 109 | Abnormal biliary tract morphology (HP:0012440) | 2.15923516 |
| 110 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.14824242 |
| 111 | Joint hemorrhage (HP:0005261) | 2.14819305 |
| 112 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14633693 |
| 113 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12602444 |
| 114 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.11865636 |
| 115 | Pancreatitis (HP:0001733) | 2.11712836 |
| 116 | Abnormal tarsal ossification (HP:0008369) | 2.10184652 |
| 117 | Glomerulonephritis (HP:0000099) | 2.08708964 |
| 118 | Irritability (HP:0000737) | 2.08078195 |
| 119 | Rickets (HP:0002748) | 2.07945778 |
| 120 | Lipid accumulation in hepatocytes (HP:0006561) | 2.07262303 |
| 121 | Nephrolithiasis (HP:0000787) | 2.04618193 |
| 122 | Myoglobinuria (HP:0002913) | 2.04264100 |
| 123 | Hypokalemic alkalosis (HP:0001949) | 2.01516865 |
| 124 | Hypoalphalipoproteinemia (HP:0003233) | 2.01390898 |
| 125 | Protuberant abdomen (HP:0001538) | 2.01146232 |
| 126 | Hepatocellular carcinoma (HP:0001402) | 2.00737130 |
| 127 | Cardiovascular calcification (HP:0011915) | 2.00592997 |
| 128 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00225089 |
| 129 | Hypophosphatemia (HP:0002148) | 1.98750707 |
| 130 | Adrenal overactivity (HP:0002717) | 1.98623110 |
| 131 | Abnormality of serum amino acid levels (HP:0003112) | 1.97580920 |
| 132 | Villous atrophy (HP:0011473) | 1.96586166 |
| 133 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.96586166 |
| 134 | Petechiae (HP:0000967) | 1.96512785 |
| 135 | Abnormal pancreas size (HP:0012094) | 1.95533615 |
| 136 | Increased circulating renin level (HP:0000848) | 1.95140739 |
| 137 | Micronodular cirrhosis (HP:0001413) | 1.94887273 |
| 138 | Abnormal hair laboratory examination (HP:0003328) | 1.94614397 |
| 139 | Abnormality of sodium homeostasis (HP:0010931) | 1.93261901 |
| 140 | Dehydration (HP:0001944) | 1.91926699 |
| 141 | Hyperphosphatemia (HP:0002905) | 1.89387808 |
| 142 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.79595167 |
| 143 | Tetraparesis (HP:0002273) | 1.79128384 |
| 144 | Confusion (HP:0001289) | 1.78205432 |
| 145 | Hyperkalemia (HP:0002153) | 1.77032424 |
| 146 | Abnormality of complement system (HP:0005339) | 1.73595061 |
| 147 | Multiple lipomas (HP:0001012) | 1.72208975 |
| 148 | Glomerulosclerosis (HP:0000096) | 1.71796437 |
| 149 | Flat capital femoral epiphysis (HP:0003370) | 1.70918880 |
| 150 | Neonatal short-limb short stature (HP:0008921) | 1.70813593 |
| 151 | Ventricular arrhythmia (HP:0004308) | 1.69736405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.93749849 |
| 2 | LMTK2 | 4.31984489 |
| 3 | FRK | 4.29150981 |
| 4 | MST1R | 3.92827767 |
| 5 | BCKDK | 3.24902469 |
| 6 | FGFR2 | 2.96517287 |
| 7 | MAP2K2 | 2.94046182 |
| 8 | ERN1 | 2.83640940 |
| 9 | MST4 | 2.80011698 |
| 10 | WNK4 | 2.75114689 |
| 11 | TNIK | 2.73289253 |
| 12 | NME1 | 2.69384529 |
| 13 | MAP3K2 | 2.62682583 |
| 14 | IRAK3 | 2.48153881 |
| 15 | TAOK3 | 2.34566634 |
| 16 | INSRR | 2.23503668 |
| 17 | MAPK15 | 2.21018107 |
| 18 | NUAK1 | 2.12960290 |
| 19 | PTK6 | 2.10588789 |
| 20 | MAP2K6 | 2.10185303 |
| 21 | PRKG2 | 2.06265633 |
| 22 | STK38L | 2.00804001 |
| 23 | PINK1 | 1.98703601 |
| 24 | FGFR3 | 1.96904494 |
| 25 | MAP3K3 | 1.91483516 |
| 26 | STK39 | 1.76228165 |
| 27 | FGFR4 | 1.75945939 |
| 28 | PBK | 1.72705835 |
| 29 | OXSR1 | 1.72346427 |
| 30 | EPHA2 | 1.53081494 |
| 31 | EPHB2 | 1.43953510 |
| 32 | PKN2 | 1.31605520 |
| 33 | WNK3 | 1.29244303 |
| 34 | PTK2 | 1.23575047 |
| 35 | SIK1 | 1.23175780 |
| 36 | MET | 1.21952752 |
| 37 | PIK3CG | 1.21197484 |
| 38 | ERBB2 | 1.18651518 |
| 39 | PIK3CA | 1.18621088 |
| 40 | BLK | 1.14206171 |
| 41 | MYLK | 1.12264885 |
| 42 | DDR2 | 1.10844321 |
| 43 | STK3 | 1.09490841 |
| 44 | GRK6 | 1.09376441 |
| 45 | RIPK1 | 1.08836062 |
| 46 | MAP3K11 | 0.99863001 |
| 47 | PHKG1 | 0.95351765 |
| 48 | PHKG2 | 0.95351765 |
| 49 | MAPK11 | 0.94598847 |
| 50 | LATS1 | 0.91918122 |
| 51 | MAP2K1 | 0.91614957 |
| 52 | CDK12 | 0.90719110 |
| 53 | PRKAA2 | 0.89647335 |
| 54 | TTK | 0.85729278 |
| 55 | MAP3K10 | 0.84875270 |
| 56 | ERBB4 | 0.84663132 |
| 57 | MAP3K7 | 0.82472753 |
| 58 | YES1 | 0.81049499 |
| 59 | PRKCI | 0.79721313 |
| 60 | SCYL2 | 0.79345325 |
| 61 | HIPK2 | 0.77364475 |
| 62 | EPHA3 | 0.77330016 |
| 63 | CDC42BPA | 0.77064331 |
| 64 | IRAK4 | 0.77013267 |
| 65 | TLK1 | 0.76766247 |
| 66 | FLT3 | 0.76035315 |
| 67 | IRAK2 | 0.75247670 |
| 68 | DAPK2 | 0.73278213 |
| 69 | PDK2 | 0.70325514 |
| 70 | TRIB3 | 0.68249901 |
| 71 | MAP3K12 | 0.66709329 |
| 72 | TIE1 | 0.66183805 |
| 73 | MAP3K1 | 0.65180467 |
| 74 | GRK1 | 0.63667725 |
| 75 | TESK1 | 0.62071248 |
| 76 | FER | 0.60769856 |
| 77 | TBK1 | 0.60012961 |
| 78 | TEC | 0.59998159 |
| 79 | CAMK2G | 0.58030679 |
| 80 | GSK3A | 0.57050934 |
| 81 | PDK1 | 0.56926040 |
| 82 | CSK | 0.53610982 |
| 83 | IRAK1 | 0.50949537 |
| 84 | LRRK2 | 0.50936959 |
| 85 | PDPK1 | 0.50570423 |
| 86 | ADRBK2 | 0.48566171 |
| 87 | OBSCN | 0.48464341 |
| 88 | KSR2 | 0.48432265 |
| 89 | DYRK1B | 0.47946708 |
| 90 | JAK2 | 0.46398810 |
| 91 | RPS6KB2 | 0.45894522 |
| 92 | NEK9 | 0.44892475 |
| 93 | PRKACG | 0.44405833 |
| 94 | ROCK1 | 0.43949156 |
| 95 | STK4 | 0.43872261 |
| 96 | CAMK2D | 0.43032345 |
| 97 | EIF2AK3 | 0.42609470 |
| 98 | EPHB1 | 0.42128890 |
| 99 | PRKAA1 | 0.41905258 |
| 100 | PASK | 0.40974171 |
| 101 | PRKCA | 0.40026600 |
| 102 | CAMK2B | 0.38923063 |
| 103 | STK24 | 0.37841830 |
| 104 | TYK2 | 0.35353634 |
| 105 | PAK4 | 0.35280524 |
| 106 | PRKCQ | 0.33582773 |
| 107 | PRKCZ | 0.33033328 |
| 108 | BMPR1B | 0.32716442 |
| 109 | KIT | 0.30064147 |
| 110 | AURKB | 0.28053339 |
| 111 | CSNK1A1 | 0.27207096 |
| 112 | MAP3K8 | 0.27104033 |
| 113 | CHUK | 0.26918569 |
| 114 | PRKCE | 0.26906798 |
| 115 | SRC | 0.26768564 |
| 116 | PDK3 | 0.26042727 |
| 117 | PDK4 | 0.26042727 |
| 118 | ADRBK1 | 0.25872313 |
| 119 | EIF2AK1 | 0.24977853 |
| 120 | PIM2 | 0.24854355 |
| 121 | RIPK4 | 0.24736899 |
| 122 | MAP4K1 | 0.22318495 |
| 123 | ABL2 | 0.22074767 |
| 124 | NME2 | 0.21840816 |
| 125 | IKBKE | 0.20846146 |
| 126 | STK11 | 0.19900475 |
| 127 | TAOK1 | 0.19873129 |
| 128 | ZAP70 | 0.19871506 |
| 129 | STK38 | 0.19126173 |
| 130 | MATK | 0.19089511 |
| 131 | BRAF | 0.18829592 |
| 132 | NLK | 0.18187140 |
| 133 | TESK2 | 0.17906623 |
| 134 | LYN | 0.17848284 |
| 135 | RPS6KB1 | 0.17652541 |
| 136 | SGK1 | 0.17335409 |
| 137 | PRKCD | 0.17331605 |
| 138 | DAPK3 | 0.14811909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.84656845 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.02650006 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.99536789 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.82140764 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.82077224 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.77462735 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.72843000 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59859175 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43305196 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.43008387 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.33456849 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22124940 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14990190 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.12762426 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07997554 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.79092954 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.74434102 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73539204 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.73409023 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73333421 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70065248 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.67836445 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67107375 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.67054586 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64250956 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63423333 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62200959 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62198281 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.60837498 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59084161 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52034210 |
| 32 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.51911842 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.46697816 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45714907 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.44253970 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.44211115 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42565137 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42417793 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40670120 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.36300013 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35545242 |
| 42 | Mineral absorption_Homo sapiens_hsa04978 | 1.33104844 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29644525 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23351025 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18931185 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17589089 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14547201 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07176669 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.05377221 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04233502 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03552727 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00102830 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99360430 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97602131 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96517626 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96394964 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94265319 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90248762 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88636004 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87443356 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85752279 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85186913 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85151727 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82879405 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82250326 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81976246 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79404876 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.79402445 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77386665 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.76296689 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75179707 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74909265 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73332959 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72235127 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.69959493 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68834161 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67914498 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65549495 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63215802 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62036789 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61467015 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58029593 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55032445 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54212937 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51648367 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47804442 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47518728 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46848155 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.37919437 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.37589612 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.36497727 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33458817 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30224532 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29096641 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29057817 |
| 96 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27625005 |
| 97 | Protein export_Homo sapiens_hsa03060 | 0.26938195 |
| 98 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.26659763 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.24265536 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.19456843 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.18207335 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.17484407 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.17111942 |
| 104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14564448 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14161387 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.13403124 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12490357 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11593592 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.11034182 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.10297093 |
| 111 | Insulin secretion_Homo sapiens_hsa04911 | 0.09901015 |
| 112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.08374934 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.07396466 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07178861 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.06361482 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06126685 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.04899758 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.04582351 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.04491808 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.01517414 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.00863962 |

